PRIMARY T-CELL IMMUNODEFICIENCIES

被引：23
作者：
FISCHER, A
机构：
[1] INSERM U 132, Hôpital des Enfants-Malades, Paris
来源：
CURRENT OPINION IN IMMUNOLOGY | 1993年 / 5卷 / 04期
关键词：
D O I：
10.1016/0952-7915(93)90040-Y
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
The phenotypes of many primary T-cell immunodeficiencies have been described, including diseases associated with defective T-cell differentiation and/or activation. Recently, genotypes have been defined for some of them, such as X-linked severe combined immunodeficiency and CD3 deficiencies (or hyper IgM syndrome). Phenotype/genotype correlation studies open a fruitful way to a better understanding of primary T-cell immunodeficiencies.
引用
收藏
页码：569 / 578
页数：10
相关论文
共 91 条
[1]  
ABBPLEBY MW, 1992, CELL, V70, P751
[2]   SEQUENCE REQUIREMENTS FOR SPLICING OF HIGHER EUKARYOTIC NUCLEAR PRE-MESSENGER-RNA [J].
AEBI, M ;
HORNIG, H ;
PADGETT, RA ;
REISER, J ;
WEISSMANN, C .
CELL, 1986, 47 (04) :555-565
[3]   CD40 LIGAND GENE DEFECTS RESPONSIBLE FOR X-LINKED HYPER-IGM SYNDROME [J].
ALLEN, RC ;
ARMITAGE, RJ ;
CONLEY, ME ;
ROSENBLATT, H ;
JENKINS, NA ;
COPELAND, NG ;
BEDELL, MA ;
EDELHOFF, S ;
DISTECHE, CM ;
SIMONEAUX, DK ;
FANSLOW, WC ;
BELMONT, J ;
SPRIGGS, MK .
SCIENCE, 1993, 259 (5097) :990-993
[4]   PRIMARY IMMUNODEFICIENCY CAUSED BY MUTATIONS IN THE GENE ENCODING THE CD3-GAMMA SUBUNIT OF THE LYMPHOCYTE-T RECEPTOR [J].
ARNAIZVILLENA, A ;
TIMON, M ;
CORELL, A ;
PEREZACIEGO, P ;
MARTINVILLA, JM ;
REGUEIRO, JR .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (08) :529-533
[5]   THE CD40 LIGAND, GP39, IS DEFECTIVE IN ACTIVATED T-CELLS FROM PATIENTS WITH X-LINKED HYPER-IGM SYNDROME [J].
ARUFFO, A ;
FARRINGTON, M ;
HOLLENBAUGH, D ;
LI, X ;
MILATOVICH, A ;
NONOYAMA, S ;
BAJORATH, J ;
GROSMAIRE, LS ;
STENKAMP, R ;
NEUBAUER, M ;
ROBERTS, RL ;
NOELLE, RJ ;
LEDBETTER, JA ;
FRANCKE, U ;
OCHS, HD .
CELL, 1993, 72 (02) :291-300
[6]  
AUST MR, 1992, AM J HUM GENET, V51, P763
[7]   MUTATIONS IN THE DNA LIGASE-I GENE OF AN INDIVIDUAL WITH IMMUNODEFICIENCIES AND CELLULAR-HYPERSENSITIVITY TO DNA-DAMAGING AGENTS [J].
BARNES, DE ;
TOMKINSON, AE ;
LEHMANN, AR ;
WEBSTER, ADB ;
LINDAHL, T .
CELL, 1992, 69 (03) :495-503
[8]   CLASS-II-ANTIGEN-NEGATIVE PATIENT AND MUTANT B-CELL LINES REPRESENT AT LEAST 3, AND PROBABLY 4, DISTINCT GENETIC-DEFECTS DEFINED BY COMPLEMENTATION ANALYSIS [J].
BENICHOU, B ;
STROMINGER, JL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (10) :4285-4288
[9]  
BLAESE RM, 1993, PEDIATR RES, V33, P549
[10]  
Bosma M J, 1992, Immunodefic Rev, V3, P261
12345678910